Kubota Pharmaceutical Holdings Co.,Ltd.
| Industry | PHARMACEUTICAL |
| Market Segment | Growth |
| Accounting | IFRS |
| Currency | JPY |
| Fiscal Year | 2024 |
Kubota Pharmaceutical Holdings Co., Ltd. develops portfolio of drugs and devices worldwide. The company offers eyeMO remote retinal monitoring device patient-based ophthalmology suite, that includes home-based miniature and NASA high-res version optical coherence tomography devices. Its product pipeline comprises emixustat hydrochloride, which is in Phase III clinical stage used for the treatment of stargardt disease, and Phase II clinical stage used for the treatment of proliferative diabetic retinopathy. Kubota Pharmaceutical Holdings Co., Ltd. was founded in 2002 and is headquartered in Min...
Full charting with technical indicators, candlestick, and more.
About Kubota Pharmaceutical Holdings Co.,Ltd.
Kubota Pharmaceutical Holdings Co., Ltd. develops portfolio of drugs and devices worldwide. The company offers eyeMO remote retinal monitoring device patient-based ophthalmology suite, that includes home-based miniature and NASA high-res version optical coherence tomography devices. Its product pipeline comprises emixustat hydrochloride, which is in Phase III clinical stage used for the treatment of stargardt disease, and Phase II clinical stage used for the treatment of proliferative diabetic retinopathy. Kubota Pharmaceutical Holdings Co., Ltd. was founded in 2002 and is headquartered in Minato, Japan.
| Ticker | 4596 |
| Exchange | TSE |
| Sector | Pharmaceutical |
| Industry | PHARMACEUTICAL |